Should Value Investors Buy Teladoc Health (TDOC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Teladoc Health Stock a Buy?
Teladoc Health (TDOC 2.16%) hasn't been an easy stock for investors to hold -- its shares are down by a shocking 88% over the last three years. But few would deny that the company has a substantial amount of real value stemming from its extensive telehealth platform and massive base of subscribers.
Where Will Teladoc Health Be in 3 Years?
Like all companies, Teladoc Health (TDOC 2.16%) will need to evolve a lot over the next three years. The days of the telehealth operator's peak hype are now firmly in the past.
Teladoc Health, Inc. (TDOC) Piper Sandler 36th Annual Healthcare Conference (Transcript)
Teladoc Health, Inc. (NYSE:TDOC ) Piper Sandler 36th Annual Healthcare Conference December 3, 2024 12:30 PM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Jess Tassan - Piper Sandler Jess Tassan All right, my name is Jess Tassan, I cover healthcare services at Piper. I'm so excited to be here with the Teladoc team CEO, Chuck Divita in his first conference appearance, I think ever since taking the helm, and CFO, Mala Murthy.
Teladoc (TDOC) Up 27% Since Last Earnings Report: Can It Continue?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Teladoc: Why I'm Long This Inflection Stock
Teladoc Health, Inc. is currently undervalued, trading at 11x forward free cash flow, presenting a compelling investment opportunity despite its dire outlook. The company's strength lies in its scalable virtual healthcare services, with a focus on chronic condition management and international expansion. Stabilizing revenue growth rates to around 1% in 2025 is crucial for Teladoc's valuation and future prospects.
Teladoc Stock Rises 59.4% in Three Months: Is This Your Buy Signal?
TDOC's use of machine learning and AI continues to drive healthcare innovation.
Teladoc: Maybe This Goose Isn't Cooked Yet (Rating Upgrade)
Teladoc Health, Inc.'s telehealth model struggles with low utilization despite its potential, leading to consistent operating losses and a declining average revenue per member. New CEO Chuck Divita aims to revitalize Teladoc by enhancing value propositions, cutting costs, and potentially selling or restructuring the Better Help segment. Teladoc's survival hinges on cost-cutting, maintaining integrated care clients, and resolving Better Help's profitability issues, with a cautious outlook for 2025.
Teladoc Enhances Virtual Sitter With AI for Improved Care Delivery
TDOC's upgraded Virtual Sitter uses AI to prevent patient falls, boost staff efficiency and enhance care delivery, thus addressing major challenges in hospitals and health systems.
If You'd Invested $10,000 in Teladoc Stock 5 Years Ago, Here's How Much You'd Have Today
Spoiler: The news isn't pretty.
